Jublia Approval History
FDA Approved: Yes (First approved June 6, 2014)
Brand name: Jublia
Generic name: efinaconazole
Dosage form: Topical Solution
Company: Bausch Health Companies Inc.
Treatment for: Onychomycosis, Toenail
Jublia (efinaconazole) is a topical triazole antifungal for the treatment of onychomycosis of the toenails.
Development History and FDA Approval Process for Jublia
|Jun 9, 2014||Valeant Pharmaceuticals Announces FDA Approval Of Jublia for the Treatment of Onychomycosis|
|May 28, 2013||Valeant Pharmaceuticals Announces Receipt Of U.S. FDA Complete Response Letter For Efinaconazole|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.